___

• 1. Kocagöz S, Akova M, Altun B, Gür D, Hasçelik G. In vitro activities of new quinolones against Brucella melitensis isolated in a tertiary-care hospital in Turkey. Clin Microbiol Infec 2002; 8: 240-242.
• 2. Slack MPE. Gram negative coccobacilli. In: Cohen J, Powderly WG, editors. Infectious Diseases. 2nd ed. London, UK: Churchill Livingstone; 2004. pp. 2243-2264.
• 3. Hatipoglu CA, Yetkin A, Ertem GT, Tulek N. Unusual clinical presentations of brucellosis. Scand J Infect Dis 2004; 36: 694- 697.
• 4. Agalar C, Usubutun S, Turkyilmaz R. Ciprofloxacin and rifampicin versus doxycycline and rifampicin in the treatment of brucellosis. Eur J Clin Microbiol 1999; 18: 535-538.
• 5. Ariza J, Gudiol F, Pallares F, Viladrich PF, Rufi G, Correidora J, Miravitlles MR. Treatment of human brucellosis with doxycycline plus rifampin or doxycycline plus streptomycin. A randomized, double-blind study. Ann Intern Med 1992; 117: 25-30.
• 6. Pappas G, Akritidis N, Bosilkovski M, Tsianos E. Brucellosis. N Engl J Med 2005; 352: 2325-2336.
• 7. Gotuzzo E, Carrillo C. Brucella. In: Gorbach SL, Barlett JG, Blacklow NR, editors. Infectious Diseases. 3rd ed. Philadelphia, PA, USA: Lippincott, Williams & Wilkins; 2004. pp. 1717-1724.
• 8. Young EJ. Brucella species. In: Mandell GL, Bennett JE, Dolin R, editors. Mandell, Douglas, and Bennett’s Principles and Practice of Infectious Diseases. 6th ed. New York, NY, USA: Churchill Livingstone; 2005. pp. 2669-2674.
• 9. Colmenero JD, Muñoz-Roca NL, Bermudez P, Plata A, Villabos A, Reguera JM. Clinical findings, diagnostic approach, and outcome of Brucella melitensis epididymo-orchitis. Diagn Micr Infec Dis 2007; 57: 367-372.
• 10. Al Sekait MA. Seroepidemiology survey of brucellosis antibodies in Saudi Arabia. Ann Saudi Med 1999; 19: 219-222.
• 11. Karabay O, Serin E, Tamer A, Gokdogan F, Alpteker H, Ozcan A, Gündüz H. Hepatitis B carriage and Brucella seroprevalence in urban and rural areas of Bolu province of Turkey: a prospective epidemiologic study. Turk J Gastroenterol 2004; 15: 11-13.
• 12. Hussein AA, Sayed AS, El Feki MA. Seroepidemiological study on human brucellosis in Assiut Governorate. Egyptian Journal of Immunology 2005; 12: 49-56.
• 13. Colmenero JD, Reguera JM, Martos F, Sanchez-De-Mora D, Delgado M, Causse M, Martín-Farfán A, Juárez C. Complications associated with Brucella melitensis infection: a study of 530 cases. Medicine 1996; 75: 195-211.
• 14. Navarro-Martinez A, Solera J, Corredoira J, Beato JL, MartinezAlfaro E, Atienzar M, Ariza J. Epididymoorchitis due to Brucella melitensis: a retrospective study of 59 patients. Clin Infect Dis 2001; 33: 2017-2022.
• 15. Yetkin MA, Erdinc FS, Bulut C, Tulek N. Epididymoorchitis due to Brucella in Central Anatolia, Turkey. Urol Int 2005; 75: 235-238.
• 16. Akinci E, Bodur H, Cevik MA, Erbay A, Eren SS, Ziraman I, Balaban N, Atan A, Ergül G. A complication of brucellosis: epididymoorchitis. Int J Infect Dis 2006; 10: 171-177.
• 17. Bosilkovski M, Krteva L, Dimzova M, Kondova I. Brucellosis in 418 patients from the Balkan Peninsula: exposure-related differences in clinical manifestations, laboratory test results, and therapy outcome. Int J Infect Dis 2007; 11: 342-347.
• 18. Hasanjani Roushan MR, Mohrez M, Smailnejad Gangi SM, Soleimani Amiri MJ, Hajiahmadi M. Epidemiological features and clinical manifestations in 469 adult patients with brucellosis in Babol, Northern Iran. Epidemiol Infect 2004; 132: 1109-1114.
• 19. Ibrahim AI, Awad R, Shetty SD, Saad M, Bilal NE. Genitourinary complications of brucellosis. Br J Urol 1988; 61: 294- 298.
• 20. Memish ZA, Venkatesh S. Brucellar epididymo-orchitis in Saudi Arabia: a retrospective study of 26 cases and review of the literature. BJU Int 2001; 88: 72-76.
• 21. Khan MS, Humayoon MS, Al Manee MS. Epididymo-orchitis and brucellosis. Br J Urol 1989; 63: 87-89.
• 22. Afsar H, Baydar I, Sirmatel F. Epididymo-orchitis due to brucellosis. Br J Urol 1993; 72: 104-105.
• 23. Yurdakul T, Sert U, Acar A, Karalezli G, Akcetin Z. Epididymoorchitis as a complication of brucellosis. Urol Int 1995; 55: 141- 142.
• 24. Ozturk A, Ozturk E, Zeyrek F, Onur K, Sirmatel O, Kat N. Comparison of brucella and non-specific epididymorchitis: gray scale and color Doppler ultrasonographic features. Eur J Radiol 2005; 56: 256-262.
• 25. Patel PJ, Kolawole TM, Sharma N, al-Faqih S. Sonographic findings in scrotal brucellosis. J Clin Ultrasound 1988; 16: 483- 486.
• 26. Ariza J, Bosilkovski M, Cascio A, Colmenero JD, Corbel MJ, Falagas ME, Memish ZA, Roushan MR, Rubinstein E, Sipsas NV et al. Perspectives for the treatment of brucellosis in the 21st century: the Ioannina recommendations. PLoS Med 2007; 4: e317.
• 27. Naber KG, Sörgel F, Kinzig M, Weigel DM. Penetration of ciprofloxacin into prostatic fluid, ejaculate and seminal fluid in volunteers after an oral dose of 750 mg. J Urologie 1993; 150: 1718-1721.
• 28. Al-Tawfiq JA. Brucella epididymo-orchitis: a consideration in endemic area. International Brazilian Journal of Urology 2006; 32: 313-315.
• 29. Bayram MM, Kervancioglu R. Scrotal gray-scale and color Doppler sonographic findings in genitourinary brucellosis. J Clin Ultrasound 1997; 25: 443-447.
• 30. Toprak O, Ozbas G. An unusual cause of epididymo-orchitis and new therapy regimen: brucellosis. Case Reports and Clinical Practice Review 2005; 6: 12-15.
• 31. Reisman EM, Colquitt LA, Childers J, Preminger GM. Brucella orchitis: a rare cause of testicular enlargement. J Urologie 1990; 143: 821-822.
• 32. Hizli F, Uygur MC. Brucella orchitis: a rare cause of testicular mass: report of a case. Int Urol Nephrol 2006; 38: 637-639.
• 33. Ozsoy MF, Kocak N, Cavuslu S. Brucellar epididymoorchitis: a report of five cases. Klimik Derg 1998; 11: 85-88 (in Turkish with English abstract). 
• 34. Erdem H, Elaldi N, Ak O, Gulsun S, Tekin R, Ulug M, Duygu F, Sunnetcioglu M, Tulek N, Guler S et al. Genitourinary brucellosis: results of a multicentric study. Clin Microbiol Infec 2014; 20: 847-853.